Fang et al. developed FAP-targeted chimeric antigen receptor NK-92 cells for NSCLC, demonstrating increased FAP expression in A549+CAF and H226+CAF cells in nude mouse models [75]. Here, FAP is linked to non-small cell lung carcinoma.